Answers are grounded in this paper and cite their sources.
Patient A, a 1-year-and-6-month-old male, was admitted due to "fever for 2 days". Patient B, a 1-year-and-9-month-old male, the monozygotic twin brother of Patient A, was admitted due to "fever for 1 day and abnormal blood findings detected 1 h prior to admission". The twin siblings underwent bone marrow examinations and were consecutively diagnosed with acute lymphoblastic leukemia, both testing positive for the ETV6::RUNX1 fusion gene. They received chemotherapy according to the CCLG-ALL-2018 protocol for 2 years, and both achieved complete remission. Since the completion of treatment, they have remained in continuous complete remission for over 2 years of follow-up. This case report provides additional clinical evidence supporting "the in utero origin" and "two-hit" hypotheses in pediatric ALL.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: